Skip to content

2007 Pipeline Report

  • Chad Cipiti
Experimental Treatments and Preventive Therapies for HIV, Hepatitis C, and Tuberculosis: By Mark Harrington, Bob Huff, and Richard Jefferys. Reviewed by Tracy Swan, Javid Syed, Claire Wingfield, and Jen Curry.
Read more

Can exhausted T cells be revived? The PD-1 palaver

  • Chad Cipiti

By Richard Jefferys May 2007 Anyone who follows HIV research is familiar with how a new potential therapeutic target can suddenly appear in the scientific literature, generating much excitement and hype, only to subsequently shuffle quietly from the scene having…

Read more

Treatment Action Group Supports Maraviroc Approval

  • Chad Cipiti

May 1, 2007 Treatment Action Group (TAG) supports the approval of maraviroc for treatment of HIV infection in patients with prior antiretroviral experience. Maraviroc is an orally-available small molecule that binds to and alters the shape of CCR5, a cell…

Read more

Palm Project Interview Series: Barbara Shacklett

  • Chad Cipiti

February 8, 2007 About the Palm Project Interviews TAG has conducted a series of interviews with leading scientists about the underlying pathogenesis of AIDS to gain insights into emerging lines of research and observations about the current research funding environment.…

Read more

Palm Project Interview Series: Douglas Nixon

  • Chad Cipiti

February 8, 2007 About the Palm Project Interviews TAG has conducted a series of interviews with leading scientists about the underlying pathogenesis of AIDS to gain insights into emerging lines of research and observations about the current research funding environment.…

Read more

Palm Project Interview Series: Steven Deeks

  • Chad Cipiti

February 8, 2007 About the Palm Project Interviews TAG has conducted a series of interviews with leading scientists about the underlying pathogenesis of AIDS to gain insights into emerging lines of research and observations about the current research funding environment.…

Read more
Back To Top